• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazines Benzothiazines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazines

Comprehensive Analysis of Despyridyl Piroxicam (Piroxicam Impurity C, CAS No. 24683-25-8): Properties, Applications, and Industry Relevance

Despyridyl Piroxicam, also known as Piroxicam Impurity C (CAS No. 24683-25-8), is a critical compound in pharmaceutical research and quality control. As an impurity of the widely used nonsteroidal anti-inflammatory drug (NSAID) Piroxicam, this molecule has garnered significant attention for its role in ensuring drug safety and efficacy. The compound's structural uniqueness, characterized by the absence of a pyridyl group compared to Piroxicam, makes it a valuable reference standard in analytical chemistry.

In recent years, the pharmaceutical industry has placed increased emphasis on impurity profiling, driven by stringent regulatory requirements from agencies like the FDA and EMA. Piroxicam Impurity C exemplifies this trend, as researchers and quality control specialists frequently search for "Piroxicam related substances", "pharmaceutical impurity standards", and "analytical reference materials". The growing demand for high-purity Despyridyl Piroxicam reflects the industry's commitment to drug safety and the need for comprehensive characterization of pharmaceutical compounds.

The analytical characterization of Despyridyl Piroxicam typically involves advanced techniques such as HPLC, LC-MS, and NMR spectroscopy. These methods are crucial for determining the compound's purity and for developing validated analytical procedures. Many researchers searching for "HPLC method for Piroxicam impurities" or "spectral data of Piroxicam Impurity C" are actively working on method development and validation studies. The compound's well-defined structure (C₁₄H₁₁N₃O₄S) facilitates these analytical processes, making it an important tool in pharmaceutical research.

From a therapeutic perspective, while Despyridyl Piroxicam itself is not pharmacologically active, its study contributes significantly to our understanding of Piroxicam's degradation pathways. This knowledge is particularly relevant given the current focus on drug stability and shelf-life extension. Pharmaceutical scientists frequently investigate topics like "Piroxicam degradation products" and "forced degradation studies", where Piroxicam Impurity C often appears as a key analyte. These studies are essential for developing stable formulations and ensuring product quality throughout the drug's lifecycle.

The synthesis and isolation of Despyridyl Piroxicam present interesting challenges for organic chemists. Current research trends show growing interest in "green chemistry approaches to pharmaceutical impurities" and "sustainable impurity synthesis". The compound's production typically involves controlled modifications of the Piroxicam structure, requiring precise reaction conditions to ensure high yield and purity. These synthetic efforts not only provide reference materials but also contribute to our understanding of structure-activity relationships in the oxicam class of compounds.

In the context of regulatory compliance, Piroxicam Impurity C serves as an important marker for quality assessment. Regulatory submissions increasingly require comprehensive data on "genotoxic impurities" and "potentially harmful degradation products". While Despyridyl Piroxicam is not classified as genotoxic, its thorough characterization helps establish safety thresholds for Piroxicam formulations. This aspect is particularly relevant given the current industry focus on "ICH guidelines for impurities" and "Q3A/B compliance".

The commercial availability of Despyridyl Piroxicam as a high-purity reference standard has facilitated global pharmaceutical development. Suppliers and researchers alike search for terms like "Piroxicam Impurity C supplier" and "certified reference materials", highlighting the compound's importance in the pharmaceutical supply chain. The consistent demand for well-characterized impurities like Piroxicam Impurity C underscores the pharmaceutical industry's commitment to quality and safety standards.

Looking forward, the study of Despyridyl Piroxicam continues to evolve with advancements in analytical technology. Emerging techniques such as "high-resolution mass spectrometry" and "multidimensional chromatography" are providing new insights into impurity characterization. These developments align with current industry searches for "advanced impurity detection methods" and "cutting-edge pharmaceutical analysis". As regulatory standards become more rigorous, the role of well-characterized impurities like Piroxicam Impurity C will only grow in importance.

In conclusion, Despyridyl Piroxicam (CAS No. 24683-25-8) represents more than just a pharmaceutical impurity—it embodies the pharmaceutical industry's dedication to quality, safety, and continuous improvement. From analytical method development to regulatory compliance, this compound plays a multifaceted role in modern drug development. As research continues to address questions about "pharmaceutical impurity control" and "drug substance characterization", Piroxicam Impurity C will remain a valuable reference point in pharmaceutical science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)